Wick Capital Partners, LLC Cor Medix Inc. Transaction History

Wick Capital Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$2.94 - $4.24 $129,360 - $186,560	-44,000 Reduced 36.98%	74,973 $317,000
Q4 2023 Feb 13, 2024	BUY	$3.0 - $4.01 $248,964 - $332,781	82,988 Added 230.62%	118,973 $447,000
Q3 2023 Nov 14, 2023	BUY	$3.6 - $4.46 $41,526 - $51,446	11,535 Added 47.18%	35,985 $133,000
Q2 2023 Aug 11, 2023	SELL	$3.94 - $5.8 $119,776 - $176,320	-30,400 Reduced 55.42%	24,450 $96,000
Q1 2023 May 15, 2023	BUY	$3.22 - $4.61 $176,617 - $252,858	54,850 New	54,850 $227,000
Q2 2022 Aug 15, 2022	BUY	$2.73 - $5.61 $313,122 - $643,450	114,697 New	114,697 $461,000

109

17.4M

134K

441K

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $502M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

Get notified when there are updates to the investment portfolio of Wick Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Wick Capital Partners, LLC with notifications on news.